Red flag symptoms requiring urgent assessment include: Severe abdominal pain or distension that is progressive or unrelieved Nausea and vomiting, particularly if unable to tolerate oral intake Inability to pass gas or persistent vomiting (possible signs of obstruction) Rectal bleeding or black, tarry stools suggesting gastrointestinal bleeding Unintentional weight loss beyond expected therapeutic effects Fever accompanying constipation, which may indicate infection or inflammation Signs of dehydration (extreme thirst, dry mouth, dizziness, dark urine) Patients with pre-existing gastrointestinal conditionsincluding inflammatory bowel disease, previous bowel obstruction, or diverticular diseaseshould have lower thresholds for seeking medical advice
If constipation persists despite these measures, healthcare providers may consider temporarily delaying dose increases or reducing the tirzepatide dose
Yes, some common potential side effects may include nausea, diarrhea, abdominal pain or headaches
No, Semaglutide (Wegovy) treatment starts at 0.25 mg weekly for the first four weeks
Semaglutide is an FDA-approved medication originally developed for managing type 2 diabetes
The Trustpilot pattern and the BBB pattern point in opposite directions, which makes the reputation picture inconsistent rather than uniformly positive
